In Texas Top Cop Shop, Inc. et al. v. Merrick Garland, a U.S. District Court in Texas has issued a potentially major setback to the continued application of the Corporate Transparency Act (CTA), which became effective on January 1, 2024. The CTA was passed in 2021 to help gather information to assist in the support of anti-money laundering and anti-terrorism investigations and enforcement of related laws. However, the CTA required onerous reporting requirements for companies, while providing exceptions for large entities. The anticipated impact of the CTA on investment entities, small businesses, and other complex structures related to corporate governance was considered significant.Continue reading
Category Archives: AZBio News
AZBio Hosts National and State Biotech Leaders in Phoenix
Leaders from the Biotechnology Innovation Organization (BIO) and members of the Council of State Biotech Associations (CSBA) came together in Phoenix from December 3-5, 2024 to share ideas and benchmark best practices as we prepare for the year ahead at the CSBA Annual Summit.Continue reading
ASU on the cusp of becoming a $1B research university
University’s growth into research powerhouse the result of President Crow’s vision, community and state support, and innovative approaches across fields and disciplinesContinue reading
Arizona Commerce Authority Announces 2024 Arizona Innovation Challenge Awardees
PHOENIX, AZ (December 2, 2024) — The Arizona Commerce Authority (ACA) announced today 10 awardees have been selected for the 2024 Arizona Innovation Challenge (AIC). The AIC is designed to advance innovation and technology commercialization opportunities in Arizona by helping early-stage ventures scale.
New Report Finds Bioscience Sector Generates Over $3 Trillion for U.S. Economy
Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic performance, its impacts, and its geographic footprint.Continue reading
Hao Yan of the ASU Biodesign Institute to be honored as a Regents Professor
Regents Professor is the highest faculty award possible at Arizona’s state universities and is conveyed by the Arizona Board of Regents.
Hao Yan is director of the Biodesign Center for Molecular Design and Biomimetics and the Milton D. Glick Distinguished Professor in the School of Molecular Sciences at Arizona State University.Continue reading
The Pause Technologies Inc. Wins First Place in the HITLAB x Versalie™ Innovation Challenge
[Phoenix, AZ] — November 22nd, 2024 — The Pause Technologies Inc., the company behind the innovative menopause management platform thePause™, has been awarded first place in the prestigious HITLAB x Versalie™ Innovation Challenge. Selected from hundreds of innovative submissions, this accolade highlights thePause™’s mission to make menopause support accessible and personalized through their digital health platform. The company will receive a $25,000 prize to continue advancing its impactful work.Continue reading
CND Life Sciences Receives Grant from The Michael J. Fox Foundation to Study Quantification of Cutaneous Phosphorylated Alpha-Synuclein (P-SYN) in People with Parkinson’s Disease
Grant funding will support the new Syn-Q Clinical Study to further investigate the quantification of P-SYN in skin biopsies using CND’s Syn-One Test®Continue reading
AdvaMed Welcomes Bipartisan Senate Bill to Expedite Medicare Coverage of Breakthrough Medical Technologies, Diagnostic Tests
Washington, D.C. – AdvaMed, the Medtech Association, today welcomed introduction in the U.S. Senate of bipartisan legislation to expedite Medicare coverage of FDA-“breakthrough”-designated medical technologies and diagnostic tests. The legislation, the Ensuring Patient Access to Critical Breakthrough Products Act, introduced by Sen. Todd Young (R-IN) and Sen. Alex Padilla (D-CA), is similar to H.R. 1691, which the U.S. House of Representatives Ways and Means Committee passed on a bipartisan basis in June. Continue reading
Over 2,100 Patients Implanted with the SynCardia Total Artificial Heart!
Tucson, AZ, Nov 20, 2024, SynCardia Systems, LLC., a Picard Medical Inc. company, is proud to announce that it has surpassed the 2,100-patient mark of SynCardia Total Artificial Hearts implants.Continue reading